Skip to content
2000
Volume 14, Issue 2
  • ISSN: 1573-4080
  • E-ISSN: 1875-6662

Abstract

Background: Based on the sequences of their catalytic domains, the astacins can be grouped into several major subfamilies such as digestive and hatching enzymes, meprin cluster and BMP1/ Tolloid like Proteases (BTP). Ethylene Diamine Tetra-Acetate (EDTA) was used to dock into the active site cleft of the astacins to know the interaction network and to identify the important residues for binding. Introduction: Comparative analysis of the binding interactions helps to reveal the binding affinity of the ligand to the astacins. Virtual alanine screening helps to identify the hotspot residues on the protease which act as potential contributors to protein-ligand stability. Pharmacophore analysis generates common features among all three clusters of the astacin family which helps in significant interactions between the astacins and EDTA. Methods: Comparative homology modeling and docking study were performed by MODELLER 9.10 and LibDock respectively. To know the importance of interacting residues, in silico alanine scanning was done. Pharmacophore modeling was elaborated by using the information obtained from receptorligand complexes. Results: Homology model explained the structure and function of the unknown astacins. It was observed that several interactions such as hydrogen bonding, pi-sigma, electrostatic and van der Waal's were involved in EDTA binding. The important pharmacophoric features such as hydrogen bond acceptor, positive ionisable and negative ionisable are involved in significant interactions between astacins and EDTA. Conclusion: Understanding the inhibitor selectivity of astacins via the contribution of specific residues could help in the design of better therapeutics targeting astacins with high binding affinity.

Loading

Article metrics loading...

/content/journals/cei/10.2174/1573408013666171106160616
2018-08-01
2025-10-09
Loading full text...

Full text loading...

/content/journals/cei/10.2174/1573408013666171106160616
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test